Index by Author
September/October 2016; Volume 70,Issue 5
B
Bakhshayeshi, Meisam
- You have accessSession 4.1: Case Studies of Application of Generic Claims and QbD for Viral ClearanceRachel Specht and Meisam BakhshayeshiPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 462-469; DOI: https://doi.org/10.5731/pdajpst.2016.006957
- You have accessSession 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation StrategiesMeisam Bakhshayeshi and Rachel SpechtPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 470-476; DOI: https://doi.org/10.5731/pdajpst.2016.006965
Blümel, Johannes
- You have accessSession 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed ExperimentsGlen Bolton and Johannes BlümelPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 477-481; DOI: https://doi.org/10.5731/pdajpst.2016.006973
- You have accessSession 2: Company-Specific Data on Cycled Resin TestingJohannes Blümel and Kurt BrorsonPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 428-442; DOI: https://doi.org/10.5731/pdajpst.2016.006924
Bolton, Glen
- You have accessSession 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed ExperimentsGlen Bolton and Johannes BlümelPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 477-481; DOI: https://doi.org/10.5731/pdajpst.2016.006973
- You have accessIntroduction: Proceedings of the 2015 Viral Clearance SymposiumGlen Bolton and Rich LevyPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 409; DOI: https://doi.org/10.5731/pdajpst.2016.006874
Brorson, Kurt
- You have accessSession 2: Company-Specific Data on Cycled Resin TestingJohannes Blümel and Kurt BrorsonPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 428-442; DOI: https://doi.org/10.5731/pdajpst.2016.006924
Buhlmann, Bob
- You have accessPDA Points To Consider: Fundamental Concepts in Data IntegrityBob Buhlmann, Madlene Dole and Zena KaufmannPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062
C
Chen, Dayue
- You have accessSession 3.1: Protein A, Hydroxyapatite, and Mixed-Mode ChromatographyDayue ChenPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 443-450; DOI: https://doi.org/10.5731/pdajpst.2016.006932
D
Dole, Madlene
- You have accessPDA Points To Consider: Fundamental Concepts in Data IntegrityBob Buhlmann, Madlene Dole and Zena KaufmannPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062
G
Gallo, Christopher
- You have accessSession 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.Christopher GalloPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 451-461; DOI: https://doi.org/10.5731/pdajpst.2016.006940
K
Kaufmann, Zena
- You have accessPDA Points To Consider: Fundamental Concepts in Data IntegrityBob Buhlmann, Madlene Dole and Zena KaufmannPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062
L
Levy, Rich
- You have accessIntroduction: Proceedings of the 2015 Viral Clearance SymposiumGlen Bolton and Rich LevyPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 409; DOI: https://doi.org/10.5731/pdajpst.2016.006874
M
Ma, Junfen
- You have accessSession 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral InactivationJunfen Ma and David RoushPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 410-416; DOI: https://doi.org/10.5731/pdajpst.2016.006890
- You have accessViral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive FiltrationDavid Roush and Junfen MaPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 417-427; DOI: https://doi.org/10.5731/pdajpst.2016.006916
R
Roush, David
- You have accessSession 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral InactivationJunfen Ma and David RoushPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 410-416; DOI: https://doi.org/10.5731/pdajpst.2016.006890
- You have accessViral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive FiltrationDavid Roush and Junfen MaPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 417-427; DOI: https://doi.org/10.5731/pdajpst.2016.006916
S
Specht, Rachel
- You have accessSession 4.1: Case Studies of Application of Generic Claims and QbD for Viral ClearanceRachel Specht and Meisam BakhshayeshiPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 462-469; DOI: https://doi.org/10.5731/pdajpst.2016.006957
- You have accessSession 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation StrategiesMeisam Bakhshayeshi and Rachel SpechtPDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 470-476; DOI: https://doi.org/10.5731/pdajpst.2016.006965
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 70, Issue 5
September/October 2016
